Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Capital Expenditures (2023 - 2025)

Vsee Health's Capital Expenditures history spans 3 years, with the latest figure at $7152.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 50.25% year-over-year to $7152.0; the TTM value through Dec 2025 reached $29928.0, up 48.61%, while the annual FY2025 figure was $29928.0, 45.85% down from the prior year.
  • Capital Expenditures reached $7152.0 in Q4 2025 per VSEE's latest filing, down from $7310.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $11873.0 in Q1 2025 to a low of $1645.0 in Q4 2023.
  • Average Capital Expenditures over 3 years is $6258.4, with a median of $6073.0 recorded in 2024.
  • Peak YoY movement for Capital Expenditures: surged 189.36% in 2024, then soared 35.85% in 2025.
  • A 3-year view of Capital Expenditures shows it stood at $1645.0 in 2023, then soared by 189.36% to $4760.0 in 2024, then skyrocketed by 50.25% to $7152.0 in 2025.
  • Per Business Quant, the three most recent readings for VSEE's Capital Expenditures are $7152.0 (Q4 2025), $7310.0 (Q3 2025), and $3593.0 (Q2 2025).